Pewter Zebra Keyfobs/Pendants

By |2021-09-11T09:23:41-04:00August 23rd, 2021|Awareness, News|

Volunteers create one-of-a-kind handmade Pewter Zebra Keyfobs/Pendants to help raise awareness & funds for CNETS Al Gillis is a neuroendocrine cancer patient and member of the Toronto Patient and [...]

Comments Off on Pewter Zebra Keyfobs/Pendants

Temozolomide Access in Ontario

By |2021-07-07T21:48:16-04:00July 6th, 2021|Treatment News|

CNETS is pleased to share the news that the oral chemotherapy drug, temozolomide, often used in combination with capecitabine, known as the CAPTEM regimen, is now more accessible to [...]

Comments Off on Temozolomide Access in Ontario

Lutathera Funded in Saskatchewan

By |2021-07-06T18:30:28-04:00July 6th, 2021|Treatment News|

As of June 1, 2021, Lutathera is now available in Saskatchewan. The reimbursement criteria is for patients with unresectable, well-differentiated midgut* neuroendocrine tumors (NET) in patients who have experienced [...]

Comments Off on Lutathera Funded in Saskatchewan

LUTATHERA Funded In British Columbia

By |2021-05-30T15:16:40-04:00March 8th, 2021|Treatment News|

CNETS is happy to announce that BC Cancer will now reimburse LUTATHERA for the approved indication. The BC Cancer Benefit Drug List, Published March 2021, Tumour Site: Gastrointestinal Peptide [...]

Comments Off on LUTATHERA Funded In British Columbia

INSPIRATIONAL NET CANCER PATIENT STORY

By |2021-05-30T15:17:55-04:00February 11th, 2021|News|

INSPIRATIONAL NEUROENDOCRINE CANCER PATIENT STORY Long-time CNETS fundraisers Bryde Fresque and Natalie Mezey, share a message of hope! As outlined in this Ottawa Hospital Foundation report, Bryde Fresque [...]

Comments Off on INSPIRATIONAL NET CANCER PATIENT STORY

ESMO Guidelines: Lung & Thymic Carcinoids

By |2021-05-30T15:18:56-04:00February 4th, 2021|Publication|

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Published January 19, 2021 Highlights This updated ESMO Clinical Practice Guideline [...]

Comments Off on ESMO Guidelines: Lung & Thymic Carcinoids
Go to Top